Vivani Medical, Inc. Common Stock (DE) (VANI)

Price$1.29

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-18.15%

Price vs S&P 500 (4W)-7.91%

VGM Score63.92

Market Capitalization$113.83M

All Metrics

Book Value / Share (Quarterly)$0.23

P/TBV (Annual)1.10x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.31

Price vs S&P 500 (YTD)-3.62%

Gross Margin (TTM)36.39%

Net Profit Margin (TTM)-993.79%

EPS (TTM)$-0.41

10-Day Avg Trading Volume0.23M

EPS Excl Extra (TTM)$-0.41

EPS (Annual)$-0.42

ROI (Annual)-130.61%

Gross Margin (Annual)36.39%

Net Profit Margin (5Y Avg)-583.18%

Cash / Share (Quarterly)$0.23

ROA (Last FY)-55.34%

EBITD / Share (TTM)$-0.40

ROE (5Y Avg)-151.99%

Operating Margin (TTM)-1004.73%

Cash Flow / Share (Annual)$-0.33

P/B Ratio5.96x

P/B Ratio (Quarterly)4.44x

Net Income / Employee (Annual)$-547,600

Net Interest Coverage (TTM)-4.01x

ROA (TTM)-79.85%

EPS Incl Extra (Annual)$-0.42

Current Ratio (Annual)2.71x

Quick Ratio (Quarterly)3.02x

3-Month Avg Trading Volume0.31M

52-Week Price Return10.00%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.51

P/S Ratio (Annual)33.68x

Asset Turnover (Annual)0.20x

52-Week High$1.92

Operating Margin (5Y Avg)-586.01%

EPS Excl Extra (Annual)$-0.42

CapEx CAGR (5Y)28.87%

Tangible BV CAGR (5Y)41.24%

26-Week Price Return-2.22%

Quick Ratio (Annual)2.56x

13-Week Price Return5.60%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.18x

Enterprise Value$94.08M

Asset Turnover (TTM)0.12x

Book Value / Share Growth (5Y)-23.27%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)-0.97x

Pretax Margin (Annual)-993.79%

Cash / Share (Annual)$0.21

3-Month Return Std Dev68.42%

Gross Margin (5Y Avg)-2.08%

Net Income / Employee (TTM)$-644,900

ROE (Last FY)-130.61%

Net Interest Coverage (Annual)-0.06x

EPS Basic Excl Extra (Annual)$-0.42

Receivables Turnover (TTM)3.85x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.41

Receivables Turnover (Annual)7.04x

ROI (TTM)-264.04%

P/S Ratio (TTM)33.68x

Pretax Margin (5Y Avg)-583.18%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.87

Price vs S&P 500 (52W)-18.21%

Year-to-Date Return7.32%

5-Day Price Return10.00%

EPS Normalized (Annual)$-0.42

ROA (5Y Avg)-96.95%

Net Profit Margin (Annual)-993.79%

Month-to-Date Return-1.49%

Cash Flow / Share (TTM)$-0.55

EBITD / Share (Annual)$-0.45

Operating Margin (Annual)-1004.44%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-151.99%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.41

P/TBV (Quarterly)1.86x

P/B Ratio (Annual)5.70x

Inventory Turnover (TTM)-0.97x

Pretax Margin (TTM)-993.79%

Book Value / Share (Annual)$0.21

Price vs S&P 500 (13W)-4.15%

Beta2.37x

Revenue / Share (TTM)$0.00

ROE (TTM)-264.04%

52-Week Low$0.92

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.08est. -0.08

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.11

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
VANIVivani Medical, Inc. Common Stock (DE)	—	—	B	$1.29
MDTMedtronic plc	B	D	D	$73.98
MASIMasimo Corporation	D	D	B	$178.59
LIVNLivaNova PLC Ordinary Shares	C	C	B	$73.81
ITGRInteger Holdings Corporation	B	C	C	$90.16
TMDXTransMedics Group, Inc. Common Stock	C	B	F	$67.53
AXGNAxogen, Inc. Common Stock	F	B	B	$38.72
BLFSBioLife Solutions Inc.	F	B	B	$26.63
CNMDCONMED Corporation	A	C	D	$34.65
INMDInMode Ltd. Ordinary Shares	A	D	C	$13.59
CBLLCeriBell, Inc. Common Stock	D	A	C	$17.61

About

Vivani Medical is a clinical-stage biopharmaceutical company developing miniature subdermal implants using proprietary NanoPortal technology to deliver medications for chronic diseases with once or twice-yearly dosing. The platform addresses a critical market need by enabling long-term, consistent drug delivery to improve medication adherence. Its flagship candidates focus on GLP-1 delivery, competing in the rapidly growing metabolic disease market alongside established drugs like Ozempic and Wegovy.